ARTICLE | Company News
Arc Pharma, University of British Columbia deal
November 4, 2002 8:00 AM UTC
Arc received exclusive worldwide rights to the university’s IP covering a class of compounds to treat surgical adhesions, arthritis and psoriasis. The university will receive milestones, royalties and...